PapersFlow Research Brief
Diagnosis and treatment of tuberculosis
Research Guide
What is Diagnosis and treatment of tuberculosis?
Diagnosis and treatment of tuberculosis refers to the clinical processes for identifying Mycobacterium tuberculosis infection through methods like imaging, PCR, and culture, and managing it with therapies, particularly addressing abdominal forms that mimic Crohn's disease, tuberculous peritonitis, and genitourinary involvement.
This field encompasses 53,281 papers focused on abdominal tuberculosis diagnosis challenges, including differentiation from Crohn's disease using imaging and PCR. Key aspects include peritoneal and genitourinary tuberculosis, with endoscopic evaluation aiding identification. Growth rate over the last 5 years is not available.
Topic Hierarchy
Research Sub-Topics
Diagnostic Imaging of Abdominal Tuberculosis
This sub-topic covers CT, MRI, and ultrasound features distinguishing peritoneal, intestinal, and nodal TB from malignancy and IBD. Researchers validate imaging criteria and radiomic signatures for early detection.
PCR Diagnosis of Tuberculous Peritonitis
Studies evaluate ascitic fluid ADA, GeneXpert, and multi-target PCR for rapid TB confirmation in high-burden settings. Research addresses sensitivity in paucibacillary effusions and genotyping.
Differential Diagnosis Abdominal TB vs Crohn's Disease
Researchers compare clinical, endoscopic, and histologic features, developing scoring systems incorporating interferon-gamma release assays. Therapeutic trials assess steroid risks in misdiagnosed cases.
Genitourinary Tuberculosis Management
This sub-topic examines diagnostic cystoscopy findings, rifampin-resistant strains, and surgical interventions for strictures and infertility. Studies track long-term renal and reproductive outcomes.
Abdominal Tuberculosis and Female Infertility
Investigators study tubal and endometrial damage mechanisms, hysterolaparoscopy findings, and fertility restoration post-anti-TB therapy. IVF success rates in treated patients are evaluated.
Why It Matters
Accurate diagnosis of abdominal tuberculosis prevents misdiagnosis as Crohn's disease, enabling timely anti-tubercular therapy that averts complications like infertility from genitourinary involvement. Dye et al. (1999) estimated 7.96 million new TB cases in 1997, including 3.52 million infectious pulmonary cases, underscoring the global scale requiring effective diagnostic tools like PCR for strain differentiation as in Kamerbeek et al. (1997). Houben and Dodd (2016) re-estimated 1.7 billion latent infections in 2014, highlighting the need for improved diagnosis and treatment of at-risk latent cases to curb progression, especially in high-HIV areas noted by Corbett et al. (2003).
Reading Guide
Where to Start
"Global Burden of Tuberculosis" by Christopher Dye et al. (1999), as it provides foundational estimates of TB scale with 7.96 million new cases in 1997, essential for understanding diagnostic and treatment priorities.
Key Papers Explained
Dye et al. (1999) in "Global Burden of Tuberculosis" establishes incidence baselines like 3.52 million infectious cases, which Corbett et al. (2003) in "The Growing Burden of Tuberculosis" extends to HIV interactions. Kamerbeek et al. (1997) in "Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology" introduces PCR tools building on burden data for practical diagnosis. Houben and Dodd (2016) in "The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling" refines latent estimates to 1.7 billion, linking to active disease risks from prior works.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current focus remains on diagnostic challenges in abdominal tuberculosis, emphasizing PCR and imaging for peritonitis and genitourinary forms, as no recent preprints or news are available.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Global Burden of Tuberculosis | 1999 | JAMA | 3.0K | ✕ |
| 2 | Simultaneous detection and strain differentiation of Mycobacte... | 1997 | Journal of Clinical Mi... | 2.9K | ✓ |
| 3 | The Growing Burden of Tuberculosis | 2003 | Archives of Internal M... | 2.6K | ✕ |
| 4 | The Global Burden of Latent Tuberculosis Infection: A Re-estim... | 2016 | PLoS Medicine | 2.0K | ✓ |
| 5 | Inflammatory bowel disease: clinical aspects and established a... | 2007 | The Lancet | 1.9K | ✕ |
| 6 | Ulcerative Colitis and Colorectal Cancer | 1990 | New England Journal of... | 1.8K | ✓ |
| 7 | WHO classification of tumours of the lung, pleura, thymus and ... | 2015 | International Agency f... | 1.7K | ✕ |
| 8 | Diagnostic Standards and Classification of Tuberculosis in Adu... | 2000 | American Journal of Re... | 1.5K | ✕ |
| 9 | The International Journal of Tuberculosis and Lung Disease | 1998 | JAMA | 1.4K | ✕ |
| 10 | Genetic requirements for mycobacterial survival during infection | 2003 | Proceedings of the Nat... | 1.4K | ✓ |
Frequently Asked Questions
What diagnostic methods are used for abdominal tuberculosis?
Imaging features and PCR diagnosis distinguish abdominal tuberculosis from conditions like Crohn's disease. Endoscopic evaluation aids in identifying tuberculous peritonitis. These methods address diagnostic challenges in peritoneal and genitourinary forms.
How does PCR contribute to tuberculosis diagnosis?
Kamerbeek et al. (1997) developed PCR for simultaneous detection and strain differentiation of Mycobacterium tuberculosis, enabling diagnosis without extended culture. This overcomes limitations of DNA restriction fragment length polymorphism requiring slow-growing cultures. It supports epidemiology and rapid clinical decisions.
What is the global burden of tuberculosis?
Dye et al. (1999) reported 7.96 million new TB cases in 1997, with 3.52 million smear-positive pulmonary cases and 16.2 million existing cases. Corbett et al. (2003) highlighted the growing burden amid the HIV pandemic. Houben and Dodd (2016) estimated 1.7 billion latent infections in 2014.
Why is latent tuberculosis infection significant?
Houben and Dodd (2016) estimated 1.7 billion people latently infected with Mycobacterium tuberculosis in 2014, a quarter of the global population. Investment in new diagnostic and treatment tools for at-risk latent cases is urged to prevent progression to active disease. This addresses the reservoir fueling ongoing transmission.
What challenges exist in differentiating abdominal tuberculosis?
Abdominal tuberculosis mimics Crohn's disease, complicating diagnosis without specific tools like imaging and PCR. Tuberculous peritonitis and genitourinary forms impact fertility, requiring precise identification. Differential diagnosis relies on endoscopic and molecular confirmation.
How does HIV affect tuberculosis control?
Corbett et al. (2003) noted the HIV pandemic as a massive challenge to global TB control. Prevention of HIV and TB co-infection, plus WHO DOTS expansion, is urgent. Focused efforts target HIV-related TB in high-prevalence areas.
Open Research Questions
- ? How can imaging and PCR be optimized to reliably differentiate abdominal tuberculosis from Crohn's disease in early stages?
- ? What molecular mechanisms allow Mycobacterium tuberculosis to persist in abdominal sites like the peritoneum and genitourinary tract?
- ? Which latent tuberculosis cases are at highest risk of progressing to abdominal forms, and how can they be targeted for preventive treatment?
- ? What genetic factors in Mycobacterium tuberculosis enable survival during abdominal infections?
- ? How do strain differentiation tools like PCR impact epidemiology of extrapulmonary tuberculosis?
Recent Trends
The field maintains 53,281 papers with no specified 5-year growth rate; foundational works like Dye et al. with 2960 citations quantify 7.96 million new cases in 1997, while Houben and Dodd (2016) update latent burden to 1.7 billion.
1999Emphasis persists on PCR advancements from Kamerbeek et al. for strain differentiation.
1997No recent preprints or news indicate ongoing refinements in abdominal diagnosis.
Research Diagnosis and treatment of tuberculosis with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Diagnosis and treatment of tuberculosis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers